FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19587011000001105: Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Nov 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66303701000001119 Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66303801000001111 Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet Is a Nevirapine 50mg modified-release tablets 180 tablet true Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet Has AMP Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) true Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet Has specific active ingredient Nevirapine true Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Viramune 50mg modified-release tablets (Boehringer Ingelheim Ltd) 180 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start